Reece E Albert
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, 655 W. Baltimore Street, Room 14-029, Baltimore, MD 21201-1559, USA.
J Matern Fetal Neonatal Med. 2010 Mar;23(3):199-203. doi: 10.3109/14767050903550659.
Gestational diabetes mellitus (GDM) is a type of diabetes that presents during pregnancy and usually disappears shortly after a woman gives birth. Better recognition of the risk factors of GDM, combined with more universal screening for the disease in many countries, has led to the increased detection of GDM along with other forms of pregestational diabetes. There is growing evidence that GDM significantly increases the risk of a number of short- and long-term adverse consequences for the fetus and mother, the most significant of which is a predisposition to the development of metabolic syndrome and Type 2 diabetes. Maternal and childhood obesity as well as cardiovascular disease are also potential long-term consequences of GDM. On the other hand, there is a growing body of evidence suggesting that the risk of many of these consequences can be significantly reduced or eliminated by aggressive treatment of GDM. There remains, however, a great deal of controversy over when to begin screening for hyperglycemia in pregnancy and at what level of hyperglycemia should aggressive intervention be initiated.
妊娠期糖尿病(GDM)是一种在孕期出现的糖尿病类型,通常在女性分娩后不久就会消失。对GDM危险因素的更好认识,再加上许多国家对该疾病进行更广泛的筛查,使得GDM以及其他形式的孕前糖尿病的检出率有所增加。越来越多的证据表明,GDM会显著增加胎儿和母亲出现一些短期和长期不良后果的风险,其中最显著的是易患代谢综合征和2型糖尿病。母亲和儿童肥胖以及心血管疾病也是GDM潜在的长期后果。另一方面,越来越多的证据表明,通过积极治疗GDM,许多这些后果的风险可以显著降低或消除。然而,对于何时开始筛查孕期高血糖以及应在何种高血糖水平启动积极干预,仍存在大量争议。